Gleason Score for Prostate Cancer

Loading...

References

  1. K Fizazi. Updated treatment recommendations for prostate cancer from the ESMO Clinical Practice Guideline considering treatment intensification and use of novel systemic agents.. Annals of oncology : official journal of the European Society for Medical Oncology, 2023
  2. R Kanesvaran. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer.. ESMO open, 2022
  3. James A Eastham. Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management.. The Journal of urology, 2022
  4. C Parker. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.. Annals of oncology : official journal of the European Society for Medical Oncology, 2020
  5. Shokhi Goel. Concordance Between Biopsy and Radical Prostatectomy Pathology in the Era of Targeted Biopsy: A Systematic Review and Meta-analysis.. European urology oncology, 2020
  6. James L Mohler. Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.. Journal of the National Comprehensive Cancer Network : JNCCN, 2019
  7. Jianming He. Validation of a Contemporary Five-tiered Gleason Grade Grouping Using Population-based Data.. European urology, 2017
  8. A. Kishan. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis.. European urology, 2017
  9. Daniel M Berney. Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome.. British journal of cancer, 2016
  10. Skyler B Johnson. Gleason pattern 5 as a pathologic predictor of recurrence, development of metastasis, and prostate cancer-specific death for patients receiving salvage radiation therapy following radical prostatectomy.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013
  11. M. Cooperberg. Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis.. Journal of the National Cancer Institute, 2009
  12. Abhijit A. Patel. PSA failure following definitive treatment of prostate cancer having biopsy Gleason score 7 with tertiary grade 5.. JAMA, 2007
  13. Patricia Harnden. Should the Gleason grading system for prostate cancer be modified to account for high-grade tertiary components? A systematic review and meta-analysis.. The Lancet. Oncology, 2007